← Leaderboards
Mark H Mirochnick
Boston University Medical Campus
$691,560
Attributed
$691,560
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $247K · FY2005–08$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$691,560 · 11
By mechanism
R21$453,458 · 1
R34$123,153 · 1
M01$114,949 · 9
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Sarah Hall Gordon$1,315,054
- Eugene R Declercq$3,162,272
- Mari-Lynn Drainoni$3,748,135
- Anita Raj$5,527,987
- Ellen M Cooper$33,386
Others in their field
Top investigators on “Perinatal”
- George R Seage · Abt Associates, Inc.$223,558,860
- Sharon A Nachman · Johns Hopkins University$210,181,743
- Barbara Driver · Westat, Inc.$170,909,028
- Elizabeth A Thom · George Washington University$155,407,274
- J Brooks Jackson · Social And Scientific Systems, Inc.$151,807,671
- Carol Nesel · Westat$147,274,423
Research focus
PerinatalHuman Therapy EvaluationVertical TransmissionClinical ResearchResearch PersonnelProtocols DocumentationHuman Pregnant SubjectWomen'S HealthGrantAids TherapyChemopreventionWomanPregnancyBirthPatient Currently PregnantPharmaceutical PreparationsPregnant WomenFundingDrug CombinationsComputer Retrieval Of Information On Scientific Projects DatabaseDrug KineticsEnrollmentInfant Human (0-1 Year)Caring
Grant awards (14)
Safety Pharmacokinetics & Efficacy of Artemether & Lumefantrine in Pregnant Women$123,153
R34 · FY2008 · AI · contact PI
PERINATAL CORE PROTOCOL FOR HIV INFECTED WOMEN (PACTG P1025, VERSION 20)$14,033
M01 · FY2007 · RR · contact PI
ANTIRETROVIRAL DRUGS DURING PREGNANCY, SUBSTUDY OF PACTG P1025$2,160
M01 · FY2007 · RR · contact PI
PHARMACOKINETICS OF ANTIRETROVIRAL DRUGS IN PREGNANT HIV INFECTED WOMEN$1,078
M01 · FY2007 · RR · contact PI
Antiretroviral Pharmacology/Lactating Mother/Infants$224,033
R21 · FY2006 · HD · contact PI
PERINATAL CORE PROTOCOL FOR HIV INFECTED WOMEN (PACTG P1025, VERSION 20)$18,571
M01 · FY2006 · RR · contact PI
ANTIRETROVIRAL DRUGS DURING PREGNANCY, HIV INFECTED WOMEN (SUB OF PACTG P1025)$4,368
M01 · FY2006 · RR · contact PI
Antiretroviral Pharmacology/Lactating Mother/Infants$229,425
R21 · FY2005 · HD
PERINATAL CORE PROTOCOL IN HIV INFECTED WOMEN (PACTG P1025, VERSION 20)$6,668
M01 · FY2005 · RR
ANTIRETROVIRAL DRUGS DURING PREGNANCY IN HIV POSITIVE FEMALES$1,668
M01 · FY2005 · RR
PERINATAL CORE PROTOCOL (PACTG P1025, VERSION 2.0)$5,429
M01 · FY2004 · RR
ACTG 316, V 1--NEVIRAPINE VERSUS NEVIRAPINE PLACEBO IN PREGNANT HIV WOMEN$0
M01 · FY2001 · RR
ACTG 316, V 1--NEVIRAPINE VERSUS NEVIRAPINE PLACEBO IN PREGNANT HIV WOMEN$30,487
M01 · FY2000 · RR
ACTG 353, V 2--NELFINAVIR COADMINISTERED W/ ZIDOVUDINE &LAMIVUDINE$30,487
M01 · FY2000 · RR